INNOVAX-ILT
Innovax-ILT is an innovative vaccine that protects against both infectious laryngotracheitis (ILT) and Marek’s disease (MD). It is a highly effective method of ILT control and provides safe, long-term protection.
Advantages
One single vaccine for long-lasting protection
No respiratory reactions — improved bird performance
Easy to apply — day-old or in ovo hatchery application
No risk of “rolling reactions” and reversion to virulence
How It Works
When Innovax-ILT is applied, it causes an immune response in the vaccinated chicken. The production of antibodies against the I and D glycoproteins stops the actual ILT virus from attaching itself to the cells to prevent infection. Innovax-ILT also results in an immune response against MD. This includes the activation of natural killer cells and macrophages, as well as the production of antibodies. Learn more by watching our Mode of Action Video.
Long-Lasting, Reaction-Free Protection
Innovax-ILT uses the herpesvirus of turkey (HVT) as its foundation to deliver long-lasting protection against both ILT and MD without the costly reactions of conventional live vaccines. Convenient to use, Innovax-ILT can be administered in a single dose in the hatchery either in ovo or by subcutaneous injection of chicks at one day of age and can be easily combined with other respiratory vaccine programs. It supplies long-term immunity without post-vaccine reactions.
Healthier Flocks, Increased Productivity
The innovative Innovax-ILT vaccine has many advantages over traditional live virus vaccines to improve overall flock health and performance. By eliminating the risk of ‘rolling reactions’ flock health is enhanced, and without the need for revaccinations in the field labor costs are also lower. Using an HVT-based vaccine delivers more effective disease control too – live ILT virus cannot be spread in the poultry facility and the risk of interference between live vaccines against other respiratory diseases is removed.
Easy-to-Administer
Effective protection begins at the hatchery with either in ovo or subcutaneous application. As a replacement for Marek’s only vaccination, Innovax-ILT does not change any hatchery vaccination processes.
Convenient to use, Innovax-ILT can be administered in a single dose in the hatchery either in ovo or by subcutaneous injection of chicks at one day of age and can be easily combined with other respiratory vaccine programs.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global